Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 27, 2026

Robotic Enucleation of Esophageal Leiomyoma
04:19

Robotic Enucleation of Esophageal Leiomyoma

Published on: February 20, 2026

399

Giant leiomyosarcoma: A case report.

Taylan Senol1, Ilker Kahramanoglu2, Bahar Muezzinoglu3

  • 1Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Kocaeli University Medical School, Kocaeli, Turkey.

International Journal of Surgery Case Reports
|January 9, 2016
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Urinary incontinence management in patients with primary endometrial cancer: A cross-sectional study by the European Network of Young Gynaecologic Oncologists (ENYGO).

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis.

JAMA network open·2025
Same author

Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lymphadenectomy in addition to bilateral pelvic SLN removal: Turkish Gynecologic Oncology Group (TRSGO-SLN-009).

Journal of gynecologic oncology·2025
Same author

Practical strategies for environmentally sustainable practices in gynecologic oncology.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Same author

Effect of the early introduction of trophic donor human breast milk on the preservation of postoperative gut functions in a fasting animal model.

The Journal of nutritional biochemistry·2025

This case highlights a rare uterine malignancy, uterine leiomyosarcoma, which can grow rapidly. Early diagnosis is challenging as it

Area of Science:

  • Gynecologic Oncology
  • Pathology

Background:

  • Uterine leiomyosarcoma is a rare malignancy of the uterus.
  • Often presents as a rapidly enlarging pelvic mass, with many patients being asymptomatic.

Purpose of the Study:

  • To report a case of an exceptionally large uterine leiomyosarcoma.
  • To emphasize the rapid clinical course and diagnostic challenges associated with this rare tumor.

Main Methods:

  • Case report of a patient with a rapidly growing abdominal mass.
  • Surgical intervention via laparotomy.
  • Confirmation of diagnosis through pathologic and histologic examination.

Main Results:

  • The patient presented with a large abdominal mass and fatigue.
Keywords:
LeiomyomaLeiomyosarcomaSize

Related Experiment Videos

Last Updated: Mar 27, 2026

Robotic Enucleation of Esophageal Leiomyoma
04:19

Robotic Enucleation of Esophageal Leiomyoma

Published on: February 20, 2026

399
  • The leiomyosarcoma exhibited a rapid growth rate, with a potential doubling time of four weeks.
  • Post-surgical recurrence led to death within four months.
  • Conclusions:

    • Uterine leiomyosarcomas can have a rapid clinical progression.
    • Preoperative differentiation between uterine sarcoma and benign leiomyomas remains difficult.
    • This case represents the largest uterine leiomyosarcoma documented in medical literature.